DrugCite
Search

MEPROBAMATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Meprobamate Adverse Events Reported to the FDA Over Time

How are Meprobamate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Meprobamate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Meprobamate is flagged as the suspect drug causing the adverse event.

Most Common Meprobamate Adverse Events Reported to the FDA

What are the most common Meprobamate adverse events reported to the FDA?

Drug Toxicity
82 (3.5%)
Completed Suicide
59 (2.52%)
Cardiac Arrest
55 (2.35%)
Respiratory Arrest
46 (1.96%)
Death
36 (1.54%)
Fall
34 (1.45%)
Multiple Drug Overdose
33 (1.41%)
Cardio-respiratory Arrest
32 (1.37%)
Drug Abuse
32 (1.37%)
Accidental Death
30 (1.28%)
Overdose
25 (1.07%)
Show More Show More
Confusional State
24 (1.02%)
Depression
23 (.98%)
Pulmonary Congestion
23 (.98%)
Accidental Overdose
21 (.9%)
Coma
20 (.85%)
Drug Ineffective
20 (.85%)
Pulmonary Oedema
20 (.85%)
Suicide Attempt
20 (.85%)
Hyponatraemia
18 (.77%)
Depressed Level Of Consciousness
17 (.73%)
Excoriation
17 (.73%)
Syncope
16 (.68%)
Drug Exposure During Pregnancy
15 (.64%)
Hypotension
15 (.64%)
Loss Of Consciousness
15 (.64%)
Back Pain
14 (.6%)
Drug Abuser
14 (.6%)
General Physical Health Deteriorati...
13 (.56%)
Injury
13 (.56%)
Fatigue
12 (.51%)
Multiple Drug Overdose Intentional
12 (.51%)
Muscle Spasms
12 (.51%)
Poisoning
12 (.51%)
Somnolence
12 (.51%)
Tremor
12 (.51%)
Agitation
11 (.47%)
Aspartate Aminotransferase Increase...
11 (.47%)
Cellulitis
11 (.47%)
Drug Interaction
11 (.47%)
Multiple Drug Overdose Accidental
11 (.47%)
Renal Failure Acute
11 (.47%)
Respiratory Distress
11 (.47%)
Speech Disorder
11 (.47%)
Contusion
10 (.43%)
Disorientation
10 (.43%)
Drowning
10 (.43%)
Drug Dependence
10 (.43%)
Drug Withdrawal Syndrome
10 (.43%)
Erectile Dysfunction
10 (.43%)
Hallucination
10 (.43%)
Headache
10 (.43%)
Hypothermia
10 (.43%)
Intervertebral Disc Protrusion
10 (.43%)
Nausea
10 (.43%)
Pain In Extremity
10 (.43%)
Road Traffic Accident
10 (.43%)
Skin Laceration
10 (.43%)
Vomiting
10 (.43%)
Abdominal Pain
9 (.38%)
Blister
9 (.38%)
Constipation
9 (.38%)
Convulsion
9 (.38%)
Hepatitis Fulminant
9 (.38%)
Malaise
9 (.38%)
Metabolic Acidosis
9 (.38%)
Subarachnoid Haemorrhage
9 (.38%)
Wound
9 (.38%)
Ankle Fracture
8 (.34%)
Arthralgia
8 (.34%)
Basal Cell Carcinoma
8 (.34%)
Body Temperature Increased
8 (.34%)
Erythema
8 (.34%)
Fibula Fracture
8 (.34%)
Foot Fracture
8 (.34%)
Impaired Healing
8 (.34%)
Joint Swelling
8 (.34%)
Maternal Drugs Affecting Foetus
8 (.34%)
Restlessness
8 (.34%)
Unresponsive To Stimuli
8 (.34%)
Activities Of Daily Living Impaired
7 (.3%)
Anxiety
7 (.3%)
Aspiration
7 (.3%)
Atrioventricular Block First Degree
7 (.3%)
Dysarthria
7 (.3%)
Facial Paresis
7 (.3%)
Head Injury
7 (.3%)
Hypoaesthesia
7 (.3%)
Incorrect Dose Administered
7 (.3%)
Insomnia
7 (.3%)
Intentional Overdose
7 (.3%)
Memory Impairment
7 (.3%)
Pneumonia Aspiration
7 (.3%)
Poisoning Deliberate
7 (.3%)
Rhabdomyolysis
7 (.3%)
Spinal Osteoarthritis
7 (.3%)
Substance Abuse
7 (.3%)
Suicidal Ideation
7 (.3%)
Wound Secretion
7 (.3%)
Alcohol Use
6 (.26%)
Atrophy
6 (.26%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Meprobamate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Meprobamate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Meprobamate

What are the most common Meprobamate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Meprobamate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Meprobamate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Meprobamate According to Those Reporting Adverse Events

Why are people taking Meprobamate, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
113
Product Used For Unknown Indication
52
Ill-defined Disorder
46
Anxiety
24
Insomnia
23
Suicide Attempt
10
Show More Show More
Agitation
8
Depression
6
Schizophrenia
5
Pain
4
Intentional Overdose
4
Sleep Disorder
4
Completed Suicide
4
Drug Abuse
2
Accidental Poisoning
2
Nervousness
2
Panic Attack
2
Drug Abuser
2
Overdose
2
Palpitations
1
Back Pain
1
Dysgeusia
1
Intentional Misuse
1
Dementia
1
Drug Therapy
1
Alcoholism
1
Antidepressant Therapy
1
Epilepsy
1
Therapeutic Product Ineffective
1
Muscle Spasms
1
Back Disorder
1
Stress
1
Hypoaesthesia
1

Drug Labels

LabelLabelerEffective
MeprobamateHeritage Pharmaceuticals Inc25-JUN-09
MeprobamateDr.Reddy's Laboratories Limited09-SEP-09
MeprobamateTaro Pharmaceuticals U.S.A., Inc.15-JUL-11
MeprobamateTaro Pharmaceutical Industries Ltd.19-JUL-11
MeprobamateWatson Laboratories, Inc.26-JUN-12

Meprobamate Case Reports

What Meprobamate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Meprobamate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Meprobamate.